Sales 2025 by Business Segment

Sales 2025 by Geography

Historical Breakdown of Revenue by Business Segments

Operating Income: Breakdown by Business Segment

Breakdown by Business Segment (EUR)
Fiscal Period: December 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Pharmaceutical Products

          

Biopharma

- - 4.12TCr 4.39TCr 4.62TCr

CAPEX

- - -290.6Cr -319.5Cr -176.2Cr

Operating Income

- - 1.12TCr 1.13TCr 1.21TCr

Consumer Healthcare

452.3Cr 514.2Cr 523.2Cr - -

CAPEX

-7.9Cr -9.8Cr -12Cr - -

Gross Profit

- - - - -

Operating Income

149.3Cr 181Cr 143.8Cr - -

Pharmaceuticals Excl. Consumer Healthcare

2.72TCr 3.13TCr - - -

CAPEX

-147.4Cr -148.8Cr - - -

Gross Profit

- - - - -

Operating Income

940.9Cr 1.1TCr - - -

Vaccines

741.8Cr 889.5Cr - - -

CAPEX

-49Cr -62Cr - - -

Gross Profit

- - - - -

Operating Income

260.9Cr 316.8Cr - - -

Pharmaceuticals

- - - - -

CAPEX

- - - - -

Gross Profit

- - - - -

Operating Income

- - - - -

Veterinary Drugs

          

Others

- 70L - 34Cr 49Cr

Operating Income

-279.7Cr -298.1Cr -1.5Cr 5.8Cr 2.6Cr

Operating Income

- - - - -

Operating Income

- - - - -

Geographical Revenue Distribution History

Geographical breakdown of sales (EUR)
Fiscal Period: December 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

United States

1.44TCr 1.83TCr 1.85TCr 2TCr 2.22TCr

Total Assets

223.4Cr 245.7Cr 232.2Cr 2.11TCr 2.29TCr

Rest of The World

785Cr 838.6Cr 1.35TCr 1.21TCr 966Cr

Total Assets

223.2Cr 242.5Cr 208.6Cr 274.1Cr 241.4Cr

Europe (Excluding France)

- - 801.3Cr 721.3Cr 745.9Cr

Total Assets

976.5Cr 874.7Cr 814Cr 574.5Cr 773.1Cr

China

272Cr 312.3Cr - - 262.1Cr

Total Assets

- - - - 12Cr

France

- - 237.9Cr 181.4Cr 171Cr

Total Assets

325.3Cr 287.5Cr 308.5Cr 311.2Cr 312.3Cr

Europe (Excl. Russia)

975.9Cr 999.9Cr - - -

Russia

58Cr 67Cr - - -

Brazil

82Cr 93Cr - - -

South Korea

- - - - -

Asia (Excl. South Asia)

- - - - -

Total Assets

4.81TCr 4.99TCr 4.94TCr 4.34TCr -

Africa, Middle East and South Asia

- - - - -

Eurasia

- - - - -

Africa, Middle East

- - - - -

Asia

- - - - -

Other Emerging Markets

- - - - -

North America (Excluding United States)

- - 70Cr - -

Total Assets

1.4TCr 1.5TCr 1.88TCr - -

Latin America

- - - - -

Japan

165.7Cr 161.3Cr - - -

Europe

- - - - -